Difficulties in interpretation of post-mortem microbiology results in unexpected infant death: evidence from a

Jeremy W Pryce1, Martin A Weber, John C Hartley

  • 1UCL Institute of Child Health, London, UK.

Abstract

Insights

Interpreting post-mortem microbiology in sudden unexpected death in infancy (SUDI) cases lacks consensus among specialists. Evidence-based guidelines are needed to standardize the interpretation of findings and improve infant death management.

Area of Science:

  • Forensic Pathology
  • Microbiology
  • Pediatric Pathology

Background:

  • Post-mortem (PM) microbiological investigations are crucial in sudden unexpected death in infancy (SUDI) cases.
  • Infection is a known cause of SUDI, yet evidence-based guidelines for interpreting PM microbiology are lacking.
  • This deficiency complicates the management of infant deaths.

Purpose of the Study:

  • To evaluate interpretive challenges in PM microbiology results among specialists.
  • To identify areas of agreement and disagreement in classifying PM findings.
  • To highlight the need for standardized interpretation protocols.

Main Methods:

  • A cross-specialty questionnaire was distributed to 109 consultants managing infant deaths.
  • Participants assessed five standardized hypothetical SUDI cases with varying PM microbiology results.
  • Respondents categorized cases into: definite bacterial infection, probable bacterial infection, uncertain significance, or PM contamination.

Main Results:

  • A 57% response rate was achieved, with no scenario yielding complete interpretive concordance.
  • High agreement (96%) was observed for pure Group 2 pathogen growth (e.g., Group B Streptococcus).
  • Mixed growth of Group 2 pathogens showed 83% agreement, while Staphylococcus aureus presented significant interpretive difficulty.

Conclusions:

  • General agreement exists for some PM microbiology findings in SUDI, but no universal consensus was reached.
  • Significant variation in interpretation exists among specialists, particularly for organisms like Staphylococcus aureus.
  • The absence of evidence-based guidelines impacts multidisciplinary management of SUDI cases.

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...